… approach to its prevention and management with regard to the … management of oral
mucositis; we do not specifically cover distal GI tract mucositis, graft-versus-host disease, mucositis …

… , and management of oral mucositis associated with conventional cytotoxic therapies for …
Severe OM may lead to dose reductions and unplanned interruptions of cancer therapies. In …

… Oral mucositis secondary to the cancer therapy is the side-effect of treatment. Its pathogenesis
was unclear until Sonis projected a hypothesis that involved four sequential events.[ 1 ] In …

… Oral Mucositis (OM) is among the most common and dreaded toxicities of cancer therapy.
It occurs in almost all patients who receive radiation therapy in which areas of oral and …

… OM can also disrupt cancer treatment by causing delays or dose reductions of … and manage
oral mucositis more effectively, positively impacting on patient experience and recovery. …

… ; this percentage rises to about 90% for head and neck cancer patients (HNC) treated with
… a delay in antineoplastic treatment for high-grade mucositis management, resulting in a …

… cancer therapy. The first report of this intervention for preventing 5-FU-associated mucositis
… The following recommendations for use of oral cryotherapy for oral mucositis were reported …

… in cancer patient management, including utilization of molecularly targeted cancer therapies,
… the treatment of choice for oral mucositis pain in patients undergoing HSCT [I, A]. Regular …

… Oral Mucositis (OM) remains one of the most common and troubling side effects of the
antineoplastic therapy. … other light therapy for the management of oral mucositis in cancer patients. …

… Oral complications almost always occur as a consequence of treatment for head and neck
cancer. In … an overview of various methods of ameliorating and/or preventing oral mucositis. …